<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/fatal-vitamin-d-overdose-supplement-stacking-warning</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-05T08:47:01.944Z</news:publication_date>
      <news:title>Fatal Vitamin D Overdose Prompts Urgent Warning on Supplement Stacking</news:title>
      <news:keywords>vitamin-d, supplement-safety, overdose, pharmacist-warning, supplement-stacking</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-proposes-excluding-semaglutide-tirzepatide-from-compounding</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-04T14:10:49.947Z</news:publication_date>
      <news:title>FDA Proposes Ban on Compounded Weight-Loss Drug Alternatives</news:title>
      <news:keywords>FDA, semaglutide, tirzepatide, compounding pharmacy, GLP-1 medications</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/chiesi-acquires-kalvista-rare-disease-expansion</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-05-03T14:10:49.718Z</news:publication_date>
      <news:title>Chiesi Acquires KalVista for $1.9B in Rare Disease Push</news:title>
      <news:keywords>mergers-acquisitions, rare-disease, hereditary-angioedema, biotech, pharma-deals</news:keywords>
    </news:news>
  </url>
</urlset>